Microbix Biosystems Price To Sales Ratio Over Time
| MBX Stock | CAD 0.31 0.01 3.13% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Microbix Biosystems Performance and Microbix Biosystems Correlation. Microbix |
Cross Equities Price To Sales Ratio Analysis
Compare Microbix Biosystems and related stocks such as Helix BioPharma Corp, Oncolytics Biotech, and Resverlogix Corp Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HBP | 15.0824 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 19.249 | 17.32 | 20.62 |
| ONC | 43.7 M | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 61.1695 | 70.34 | 66.83 |
| RVX | 1.6 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.3 K | 2.1 K | 2 K |
| TH | 686 | 4.6688 | 8.3981 | 12.827 | 13.5614 | 21.6407 | 47.5412 | 42.4932 | 14.8753 | 10.7464 | 17.4198 | 10.3874 | 0.5103 | 0.59 | 0.56 |
| EDT | 344 | 9.4842 | 10.9969 | 27.842 | 18.2488 | 49.3145 | 15.8778 | 23.6963 | 16.3409 | 56.6689 | 44.8184 | 27.0673 | 59.8933 | 74.086 | 45.68 |
Microbix Biosystems and related stocks such as Helix BioPharma Corp, Oncolytics Biotech, and Resverlogix Corp Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Microbix Biosystems stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Microbix Biosystems sales, a figure that is much harder to manipulate than other Microbix Biosystems multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Microbix Biosystems | MBX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 265 Watline Avenue, |
| Exchange | Toronto Exchange |
CAD 0.31
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.